CSIMarket
 


Pfizer Inc  (PFE)
Other Ticker:  
 
 

PFE's Capital Expenditures Growth by Quarter and Year

Pfizer Inc's Capital Expenditures results by quarter and year




PFE Capital Expenditures (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
IV Quarter January - 1,286.00 726.00 792.00
III Quarter October - 530.00 662.00 562.00
II Quarter July - 480.00 588.00 456.00
I Quarter April 554.00 495.00 618.00 386.00
FY   554.00 2,791.00 2,594.00 2,196.00



PFE Capital Expenditures first quarter 2021 Y/Y Growth Comment
Pfizer Inc achieved in the first quarter, above Company average Capital Expenditures increase of 11.92% year on year, to $ 554.00 millions.

Looking into first quarter results within Major Pharmaceutical Preparations industry 62 other companies have achieved higher Capital Expenditures growth. While Pfizer Inc' s Capital Expenditures growth of 11.92% ranks overall at the positon no. 924 in the first quarter.




PFE Capital Expenditures ( Y/Y Growth %) 2021
2020 2019 2018
IV Quarter January - 77.13 % -8.33 % 263.3 %
III Quarter October - -19.94 % 17.79 % -26.92 %
II Quarter July - -18.37 % 28.95 % 5.56 %
I Quarter April 11.92 % -19.9 % 60.1 % -22.33 %
FY   - 7.59 % 18.12 % 14.61 %

Financial Statements
Pfizer Inc's first quarter 2021 Capital Expenditures $ 554.00 millions PFE's Income Statement
Pfizer Inc's first quarter 2020 Capital Expenditures $ 495.00 millions Quarterly PFE's Income Statement
New: More PFE's historic Capital Expenditures Growth >>


PFE Capital Expenditures (Quarter on Quarter Growth %)

2021
2020 2019 2018
IV Quarter January - 142.64 % 9.67 % 40.93 %
III Quarter October - 10.42 % 12.59 % 23.25 %
II Quarter July - -3.03 % -4.85 % 18.13 %
I Quarter April -56.92 % -31.82 % -21.97 % 77.06 %
FY (Year on Year)   - 7.59 % 18.12 % 14.61 %




Capital Expenditures first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #63
Healthcare Sector #198
Overall #924

Capital Expenditures Y/Y Growth Statistics
High Average Low
35.39 % 3.52 % -11.32 %
(Dec 31 2018)   (Sep 30 2018)
Capital Expenditures first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #63
Healthcare Sector #198
Overall #924
Capital Expenditures Y/Y Growth Statistics
High Average Low
35.39 % 3.52 % -11.32 %
(Dec 31 2018)   (Sep 30 2018)

Capital Expenditures by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Pfizer Inc's Q/Q Capital Expenditures Growth


Capital Expenditures Q/Q Growth Statistics
High Average Low
143.2 % 18.82 % -100 %
(June 30. 2011)  


PFE's I. Quarter Q/Q Capital Expenditures Comment
In the I. Quarter 2021 Pfizer Inc disclosed fall in Capital Expenditures from the previous quarter by -56.92% to $ 554.00 millions, from $ 1,286.00 millions declared in the previous reporting period.

As we look into recent shortcoming in the quarter, we suppose to take into consideration, that commonly I. Quarter performance occur weaker relative to the quarter before, Alexis B. Hill, an industry advisor based in Boston mentioned.

Within Major Pharmaceutical Preparations industry 113 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Pfizer Inc's Capital Expenditures growth quarter on quarter, overall rank is 2011.


Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #114
Healthcare Sector #343
Overall #2011
Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #114
Healthcare Sector #343
Overall #2011
Capital Expenditures Q/Q Growth Statistics
High Average Low
143.2 % 18.82 % -100 %
(June 30. 2011)  


PFE's I. Quarter Q/Q Capital Expenditures Comment
In the I. Quarter 2021 Pfizer Inc reported fall in Capital Expenditures sequentially by -56.92% to $ 554.00 millions, from $ 1,286.00 millions declared in the previous quarter.

But that's not big concern, as Pfizer Inc's Capital Expenditures frequently tend to plunge in the I. Quarter.

Within Major Pharmaceutical Preparations industry 113 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Pfizer Inc's Capital Expenditures growth quarter on quarter, overall rank is 2011.


Pfizer Inc's 12 Months Capital Expenditures Growth Year on Year


Capital Expenditures TTM Growth

12 Months Ending
(Apr 04 2021)
12 Months Ending
(Dec 31 2020)
12 Months Ending
(Sep 27 2020)
12 Months Ending
(Jun 28 2020)
12 Months Ending
(Mar 29 2020)
Cumulative Capital Expenditures 12 Months Ending $ 2,850.00 $ 2,791.00 $ 2,231.00 $ 2,363.00 $ 2,471.00
Y / Y Capital Expenditures Growth (TTM) 15.34 % 7.59 % -16.13 % -7.7 % 1.77 %
Year on Year Capital Expenditures Growth Overall Ranking # 686 # 963 # 1644 # 1562 # 1466
Seqeuential Capital Expenditures Change (TTM) 2.11 % 25.1 % -5.59 % -4.37 % -4.74 %
Seq. Capital Expenditures Growth (TTM) Overall Ranking # 924 # 464 # 1619 # 448 # 1986




Cumulative Capital Expenditures growth Comment
Pfizer Inc saw improvement in Capital Expenditures growth trend, posting cumulative 12 months Capital Expenditures growth of 15.34% year on year, to $ 2,850 millions if the fiscal year would have ended in Apr 04 2021.
Pfizer Inc's trailing twelve months Capital Expenditures growth was higher than company's average 13.86% and higher than 7.59% growth in Dec 31 2020.
But sequential growth rate was beneth at 2.11 % from $2791 millions achieved in twelve months ending a quarter Dec 31 2020.
We witness slowdown in progress, more evident as we look at If you typical Q/Q TTM historic increase what is better at3.52% Alexis B. Hill noted.
The momentum was even more impressive sequentially clinched at 2.11 % jump from $2791 millions in the period from Dec 31 2020 to Mar 29 2020.

In the Healthcare sector 171 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Total ranking has impoved so far to 686, from total ranking in previous quarter at 963.

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
35.39 %
3.52 %
-11.32 %
 

Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 63
Healthcare Sector # 172
Overall # 686

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
64 %
13.86 %
-18.86 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 63
Sector # 198
S&P 500 # 924
Cumulative Capital Expenditures growth Comment
Pfizer Inc saw improvement in Capital Expenditures growth trend, posting cumulative 12 months Capital Expenditures growth of 15.34% year on year, to $ 2,850 millions if the fiscal year would have ended in Apr 04 2021.
Pfizer Inc's trailing twelve months Capital Expenditures growth was higher than company's average 13.86% and higher than 7.59% growth in Dec 31 2020.
But from the previous reporting period rise was less at 2.11 % from $2791 millions recorded in twelve months ending a quarter before.
It appears to be slowdown happening, more evident observing the If you typical sequential historic rise that is higher at 3.52% Alexis B. Hill wrote.
The progress was much higher sequentially clinched at 2.11 % increase from $2791 millions in the period from Dec 31 2020 to Mar 29 2020.

In the Healthcare sector 171 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Total ranking has impoved so far to 686, from total ranking in previous quarter at 963.

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
35.39 %
3.52 %
-11.32 %
 


Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 63
Healthcare Sector # 172
Overall # 686

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
64 %
13.86 %
-18.86 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 63
Sector # 198
S&P 500 # 924




Other Capital Expenditures Growth
Major Pharmaceutical Preparations Industry Capital Expenditures Growth Trends and Statistics
Healthcare Sector Capital Expenditures Growth Statistics
Capital Expenditures Growth Trends for overall market
PFE's Capital Expenditures Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Capital Expenditures Growth
Lowest Ranking Capital Expenditures Growth
Capital Expenditures Growth for PFE's Competitors
Capital Expenditures Growth for Pfizer Inc's Suppliers
Capital Expenditures Growth for PFE's Customers

You may also want to know
PFE's Annual Growth Rates PFE's Profitability Ratios PFE's Asset Turnover Ratio PFE's Dividend Growth
PFE's Roe PFE's Valuation Ratios PFE's Financial Strength Ratios PFE's Dividend Payout Ratio
PFE's Roa PFE's Inventory Turnover Ratio PFE's Growth Rates PFE's Dividend Comparisons



Companies with similar Capital Expenditures fall for the quarter ending Apr 04 2021 within Healthcare SectorY/Y Change %Capital Expenditures for the quarter ending Apr 04 2021


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

SENZ's Profile

Stock Price

SENZ's Financials

Business Description

Fundamentals

Charts & Quotes

SENZ's News

Suppliers

SENZ's Competitors

Customers & Markets

Economic Indicators

SENZ's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071